Does resveratrol reduce cisplatin-induced ovarian damage?

Rev Assoc Med Bras (1992). 2023 Aug 14;69(8):e20230314. doi: 10.1590/1806-9282.20230314. eCollection 2023.

Abstract

Objective: The objective of this study was to investigate the protectiveness of resveratrol on cisplatin-induced damage to the ovary using experimental models.

Methods: A total of 30 female Wistar-Albino rats constituted the research material. The rats were categorized into three groups: Group 1 was administered one milliliter of 0.9% NaCl solution, Group 2 was administered 7.5 mg/kg cisplatin, and Group 3 was administered 7.5 mg/kg cisplatin and 10 mg/kg resveratrol. Ovaries were extirpated in all groups and subjected to biochemical and histopathological tests. Cisplatin-induced damage to ovarian tissue was graded and scored as the total histopathological findings score. The ovarian function was assessed using immunohistochemical staining for c-kit expression. Rats' malondialdehyde, catalase, and superoxide dismutase levels were determined.

Results: The histopathological finding score was significantly higher in Group 2 than in other groups (p<0.05). The superoxide dismutase and catalase levels were significantly higher in Group 3 than in Group 2 (p<0.001 for both cases). The malondialdehyde level was significantly higher in Group 2 than in Group 3 (p<0.001).

Conclusion: The study findings demonstrated that resveratrol reduced ovarian injury and enhanced biochemical parameters following cisplatin-induced ovary damage in experimental models.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Catalase
  • Cisplatin* / metabolism
  • Cisplatin* / toxicity
  • Female
  • Malondialdehyde
  • Ovary*
  • Oxidative Stress
  • Rats
  • Rats, Wistar
  • Resveratrol / metabolism
  • Resveratrol / pharmacology
  • Superoxide Dismutase

Substances

  • Resveratrol
  • Catalase
  • Cisplatin
  • Antioxidants
  • Superoxide Dismutase
  • Malondialdehyde